The Future of Psychedelic Medicine
Our Story
Find out what inspires us to support mental health disorders.
Our Mission
Supporting innovative therapies to help humans thrive.
Our Team
Multi-disciplinary collaboration
creating positive experiences and outcomes.
Mission
Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.
HAVN Labs
- HAVN Labs is building a psychedelic supply chain for clinical researchers. Through research, extraction, formulation and delivery of psychedelics, we aspire to define and standardize the future of modern medicine.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
350 Million
People globally are affected by a form of depression.
1 Trillion
Dollars lost annually in global workforce productivity due to depression and anxiety.
0
Formulas standardized across clinical studies of psychedelic compounds.
HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil
Through the Partnership, the Company will seek Health Canada approval to supply naturally-derived psilocybin for legal and therapeutic use via the Special Access Program Vancouver, …
HAVN Life Secures Supply Agreement with Atman Retreats
This new partnership will see the distribution of the Company’s standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Atman retreats in Jamaica Vancouver, …
HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia
The successful shipment of white label natural health products will expand the Company’s global retail footprint Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) …